We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Boehringer Ingelheim Pharmaceuticals announced that it has entered into an agreement with Johnson & Johnson (J&J) and Pfizer to acquire the U.S. rights to the over-the-counter (OTC) Zantac product line for $509.5 million in cash.
Sanofi pasteur, the vaccines arm of French drugmaker sanofi-aventis,
said it is on track to deliver its projected supply of 50 million doses of its flu vaccine, Fluzone, by the end of November.
The drug misoprostol provides a safe, convenient and inexpensive means to prevent postpartum hemorrhage, a major killer of women in developing countries, according to a study conducted by the U.S. NIH and the Jawaharlal Nehru Medical College with women in rural India.
The UNITAID International Drug Purchase Facility is expected to have as much as 300 million euros available next year for developing countries to purchase urgently needed anti-retroviral, anti-malarial and TB drugs.
Sales of drugs to treat hypertension in China will nearly double from the current level of $440 million to $800 million in 2010, according to projections from an analyst report released Tuesday.
Dutch biotechnology company Crucell N.V. announced that it has signed a non-exclusive PER.C6 commercial license agreement with the Taiwan-based vaccine company ADImmune Corporation.
Wednesday, Genentech, Inc., revealed U.S. Food and Drug Administration approval for its Avastin (bevacizumab) indicated as a first line treatment for patients with inoperable, recurrent or metastatic non-squamous, non-small cell lung cancer.
The International Federation of Red Cross and Red Crescent Societies has launched a major new AIDS initiative in Southern Africa, the world's worst affected region where more than 11 million people have HIV, reports the UN International News Service (IRIN).